Aberdeen, United Kingdom

Graeme Ian Murray

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2001-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Graeme Ian Murray: Innovator in Cancer Diagnostics

Introduction

Graeme Ian Murray is a notable inventor based in Aberdeen, GB. He has made significant contributions to the field of cancer diagnostics, holding a total of 3 patents. His work focuses on identifying novel biomarkers and therapeutic interventions for various cancers, particularly colorectal cancer.

Latest Patents

Murray's latest patents include groundbreaking research on mitochondrial stress-70 protein markers for colorectal cancer. This invention provides previously uncharacterized markers of cancers, specifically colorectal cancers, and outlines their use as diagnostic and prognostic markers. The markers identified include SEQ ID NO: 1—hnRNP-K, SEQ ID NO: 2—HMG-1, SEQ ID NO: 3—proteasome subunit alpha type 1, SEQ ID NO: 4—bifunctional purine biosynthesis protein, SEQ ID NO: 5—ST11, SEQ ID NO: 6—annexin IV, SEQ ID NO: 7—60 kDa heat shock protein, SEQ ID NO: 8—T complex protein 1 beta subunit, SEQ ID NO: 9—T complex protein 1 epsilon subunit, SEQ ID NO: 10—mortalin, and SEQ ID NO: 11—TER-ATPase. This invention also provides methods and materials for using these markers in therapeutic interventions, specifically targeting neoplastic cells while minimizing toxicity to healthy tissues.

Another significant patent involves the development of antibodies specific for CYP1B1. These antibodies can bind to cytochrome P450 CYP1B1 and are particularly useful in diagnosing and treating cancers associated with enhanced CYP1B1 expression, including breast cancer, prostate cancer, colorectal cancer, liver cancer, and ovarian cancer.

Career Highlights

Murray has worked with esteemed institutions, including the University Court of the University of Aberdeen. His research has contributed to advancements in cancer diagnostics and treatment methodologies.

Collaborations

Murray has collaborated with notable individuals in his field, including William Thomas Melvin and Michael Danny Burke. Their combined expertise has furthered the impact of his research.

Conclusion

Graeme Ian Murray's innovative work in cancer diagnostics and treatment exemplifies the importance of research in improving healthcare outcomes. His contributions continue to pave

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…